The report notes that large employers' perceptions about PBM performance have not changed much over the past 5 years. Employers continue to be more satisfied with core PBM services and ...
Congress and regulating agencies including the FTC and HHS scrutinized PBM business practices and ... down 32.2% from its 2022 performance due to biosimilar competition. One might expect that ...
Opinions expressed by Forbes Contributors are their own. I write about business model strategy and execution across healthcare. On the heels of the FTC’s investigation into pharmacy benefit ...
PBM Polytex - Board Meeting Outcome for Outcome Of The Board Meeting For The Quarter Ended 30.09.2024 Held On 13.11.2024 Outcome of the Board Meeting for the quarter ended 30.09.2024 held on 13.11 ...